Journal Mobile Options
Table of Contents
Vol. 10, No. 5, 1999
Issue release date: September–October 1999
Dement Geriatr Cogn Disord 1999;10:342–344

Acetylcholine and Delirium

Tune L.E. · Egeli S.
Division of Geriatric Psychiatry, Wesley Woods Center at Emory University, Atlanta, Ga., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The neurotransmitter acetylcholine has been implicated in animal and human studies of delirium. This chapter will briefly review the clinical studies focussing on measurement of serum levels of anticholinergic activity in delirious states. Three approaches have been taken. First, to identify medications currently prescribed that have subtle anticholinergic effects. The current ‘list’ includes 48 commonly prescribed medications. Second, to associate serum anticholinergic activity with delirium in various clinical states including postcardiotomy delirium, postelectroconvulsive delirium, delirious elderly medical inpatients, and nursing home patients. Third, to intervene in patients with elevated anticholinergic activity by reducing known anticholinergics and correlating this reduction with clinical measures of cognition and delirium. Our most recent data investigates the impact of anticholinergics on demented patients. Rates of delirium were significantly higher in patients receiving larger numbers of anticholinergics.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Gibson G, Blass JP, Huang H-M, et al: The cellular basis of delirium and its relevance to age related disorders including Alzheimer’s disease. Int Psychogeriatr 1991;3:373–395.
  2. Gjedde A, Lockwood AH, Duffy TE, et al: Cerebral blood flow and metabolism in chronically hyperammonemic rats: Effect of an acute ammonia challenge. Ann Neurol 1978;3:325–330.

    External Resources

  3. Posner JB, Plum F: The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest 1960;39:1246–1258.
  4. Tune L, Ross CA: Delirium; Coffey CE, Cummings JL (eds): Textbook of Geriatric Neuropsychiatry, Washington, APA Press, 1994, pp 35–365.
  5. Tollefson GD, Montague-Clouse J, Lancaster SP: The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatry Clin Neurosci 1991;3:314–319.
  6. Flacker J, Lipsitz LA: Serum anticholinergic activity changes with acute illness in elderly medical patients. Am J Geriatr Psychiatry 1998;6:47–54.
  7. Inouye SK, van Dyck C, Alessi CH, et al: Clarifying confusion: The confusion assessment method. Ann Intern Med 1990;113:941–948.
  8. Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons: Predictive model and interrelationship with baseline vulnerability. JAMA 1996;275:852–857.
  9. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00